Clinical Trial Update: Epoprostenol in Pulmonary Embolism [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating epoprostenol for acute pulmonary embolism has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Embolism

Drugs mentioned

• Epoprostenol (Epoprostenol)

Snippet

Sponsor: Universitair Ziekenhuis Brussel | Conditions: Acute Pulmonary Embolism | Phase 4 | Status: COMPLETED